Selecting protein tyrosine phosphatases as drug targets
- 1 October 2002
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 7 (19) , 1013-1019
- https://doi.org/10.1016/s1359-6446(02)02438-8
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Effective expression of small interfering RNA in human cellsNature Biotechnology, 2002
- U6 promoter–driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cellsNature Biotechnology, 2002
- Regulation of Insulin-Like Growth Factor Type I (IGF-I) Receptor Kinase Activity by Protein Tyrosine Phosphatase 1B (PTP-1B) and Enhanced IGF-I-Mediated Suppression of Apoptosis and Motility in PTP-1B-Deficient FibroblastsMolecular and Cellular Biology, 2002
- Metastasis in colorectal cancer associated with phosphatase expressionThe Lancet, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Introduction: Phosphatases in the immune systemSeminars in Immunology, 2000
- The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell functionSeminars in Immunology, 2000
- Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the Angiopoietin receptor Tie-2Oncogene, 1999
- Targeted disruption of the tyrosine phosphatase PTPα leads to constitutive downregulation of the kinases Src and FynCurrent Biology, 1999
- Overexpression of SAP-1, a Transmembrane-Type Protein Tyrosine Phosphatase, in Human Colorectal CancersBiochemical and Biophysical Research Communications, 1997